Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
185.50
-1.49 (-0.80%)
Oct 26, 2026, 9:40 AM EDT - Market open
Revolution Medicines Market Cap
Revolution Medicines has a market cap or net worth of $39.76 billion as of October 26, 2026. It is the 624th most valuable company in the world and the 300th biggest in the United States. Its market cap has increased by 290.41% in one year.
Market Cap
39.76B
Enterprise Value
37.01B
1-Year Change
290.41%
Global Rank
Country Rank
#300 United States
Category
ChartMarket Cap Chart
Since February 13, 2020, Revolution Medicines's market cap has increased from $1.64B to $39.76B, an increase of 2,317.75%. That is a compound annual growth rate of 60.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 39.76B | 158.21% |
| Dec 31, 2025 | 15.40B | 90.50% |
| Dec 31, 2024 | 8.08B | 71.26% |
| Dec 29, 2023 | 4.72B | 123.15% |
| Dec 30, 2022 | 2.11B | 14.03% |
| Dec 31, 2021 | 1.85B | -29.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Regeneron Pharmaceuticals | 80.39B |
| Moderna | 79.89B |
| argenx SE | 54.78B |
| BeOne Medicines AG | 42.94B |
| Royalty Pharma | 36.72B |
| Alnylam Pharmaceuticals | 29.98B |
| Roivant Sciences | 26.36B |
| Genmab | 23.67B |